Company Name | Dr. Agarwal’s Health Care Limited |
Open Date | 29-01-2025 |
Close Date | 31-01-2025 |
Exchange | BSE, NSE |
Lot Size | 35 Shares |
Issue Price | ₹279 to ₹294 per share |
Issue Size | 7,53,04,970 shares |
Application Amount | ₹ 14,070 – ₹ 1,96,980 (35 to 490 shares) |
Recommendation | Avoid |
Dr. Agarwal’s Health Care Limited was originally incorporated on April 19, 2010. The registered office is located at Chennai, Tamil Nadu, India. The company provide a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories, and eye care related pharmaceutical products. The major revenue stream for the company is from eye Surgeries. The company 737 doctors and 4,858 employees (including paramedical staff) as of September 30, 2024.
KPI’s | FY 22 | FY 23 | FY 24 | Sep-24 |
Revenue | 696.08 | 1,017.98 | 1,332.15 | 820.06 |
EBITDA | 182.12 | 270.35 | 362.26 | 210.60 |
Net Profit | 43.16 | 103.23 | 95.05 | 39.56 |
RoCE | 10.30% | 9.32% | 8.16% | 9.17%* |
ROE | 20.32% | 16.40% | 7.10% | 4.29%* |
P/E | 219.67 | 100.50 | 128.43 | 160.48* |
Opening Date | 29/01/2025 |
Closing Date | 31-01-2025 |
Basis of Allotment | 03-02-2025 |
Initiation of Refunds | 04-02-2025 |
Credit of Shares to Demat | 04-02-2025 |
Listing Date | 05-02-2025 |
Repayment/prepayment, in part or full, of certain of the borrowings |
General corporate purposes and unidentified inorganic acquisition |
Registered Office | Dr. Agarwal's Health Care Limited 1 st Floor, Buhari Towers No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006 |
Phone | +91 44 4378 7777 |
secretarial@dragarwal.com | |
Website | https://dragarwals.co.in/ |
Dr. Agarwal's Health Care IPO DRHP |
Dr. Agarwal's Health Care IPO RHP |
Name | Kfin Technologies Limited |
Phone | 04067162222, 04079611000 |
ahcl.ipo@kfintech.com | |
Website | https://kosmic.kfintech.com/ipostatus/ |
QIB Shares Offered | Not more than 50% of the Net Issue |
Retail Shares Offered | Not less than 35% of the Net Issue |
NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Share Holding Pre Issue (Promoters) | 37.73% |
Share Holding Post Issue (Promoters) | 32.53% |